alphaveCAPLIPOINT₹2,792.00

Caplin Point Laboratories Ltd.

₹ CrorePeersAJANTPHARM ERIS GLAND BLUEJET CONCORDBIO ACUTAAS EMCURE GRANULESMcap ₹21,219 Cr

View

In ₹ Crore except Per Share 12 Months Ending	FY24 31/03/2024	FY25 31/03/2025	FY26 31/03/2026	Last 12M 30/06/2026
Non-current Assets
+ Property, Plant & Equipment	438.6	530.3	547.5	547.5
+ Capital Work-in-Progress	116.6	139.2	208.6	208.6
+ Other Intangibles	12.5	11.3	32.5	32.5
+ Intangibles under Development	0.0	4.3	25.0	25.0
+ Non-current Investments	137.6	279.1	473.3	473.3
+ Other Non-current Financial Assets	12.6	22.2	28.4	28.4
Non-current Financial Assets	150.2	279.1	501.7	501.7
+ Deferred Tax Assets	12.2	2.2	8.0	8.0
+ Other Non-current Assets	75.0	110.4	136.6	136.6
Total Non-current Assets	805.2	1,074.6	1,459.8	1,459.8
Current Assets
+ Inventories	363.0	336.1	428.9	428.9
+ Current Investments	238.0	311.3	385.7	385.7
+ Trade Receivables	542.7	632.5	825.8	825.8
+ Cash & Cash Equivalents	138.7	199.5	94.2	94.2
+ Other Bank Balances	414.0	392.0	526.9	526.9
+ Other Current Financial Assets	45.5	57.4	74.2	74.2
Current Financial Assets	1,379.0	1,592.6	1,906.7	1,906.7
+ Other Current Assets	150.2	205.3	250.1	250.1
Total Current Assets	1,892.2	2,134.0	2,585.7	2,585.7
Total Assets	2,697.4	3,208.6	4,045.5	4,045.5
Equity
+ Equity Share Capital	15.2	15.2	15.2	15.2
+ Other Equity / Reserves	2,300.5	2,835.3	3,571.2	3,571.2
Equity — Owners of Parent	2,315.7	2,850.5	3,586.4	3,586.4
+ Minority Interest	31.1	35.9	44.4	44.4
Total Equity	2,346.8	2,886.4	3,630.8	3,630.8
Liabilities
+ Borrowings — Non-current	0.9	0.0	0.0	0.0
+ Other Non-current Financial Liab	10.5	2.9	2.1	2.1
Non-current Financial Liabilities	11.4	2.9	2.1	2.1
+ Provisions — Non-current	8.6	1.3	1.0	1.0
+ Deferred Tax Liabilities	0.0	0.8	12.6	12.6
+ Other Non-current Liabilities	0.0	10.8	13.1	13.1
Non-current Liabilities	20.0	15.8	28.7	28.7
+ Borrowings — Current	0.3	0.6	0.6	0.6
+ Trade Payables	209.4	217.6	296.0	296.0
+ Other Current Financial Liab	74.9	45.3	52.7	52.7
Current Financial Liabilities	284.6	263.4	349.3	349.3
+ Provisions — Current	10.3	24.0	20.0	20.0
+ Other Current Liabilities	35.6	19.0	16.6	16.6
Current Liabilities	330.6	306.4	385.9	385.9
Total Liabilities	350.6	322.2	414.7	414.7
Total Equity & Liabilities	2,697.4	3,208.6	4,045.5	4,045.5
Trade Payables — MSME split
+ Dues to Micro & Small — Current	—	2.3	9.3	9.3
+ Dues to Other Creditors — Current	—	215.3	286.8	286.8

As filed, sign as filed — read the label, not the sign. A line appears only when the company tagged that concept in at least one period shown, so depth follows the filer: pre-Ind-AS, insurance and NBFC blocks stay hidden unless they were actually reported. Alternate tags for the same idea (e.g. two spellings of a deferred-tax element) are kept as separate lines rather than merged, because merging them would be a guess. Ratios, per-share figures and counts render as raw numbers, not ₹ Crore. No consensus estimates → no Est columns. Click any row to chart it.

« ‹ › »Latest: FY26 · ConsolidatedFA Financial Analysis · alphave

Data & compliance. Descriptive financial information from official NSE/BSE filings — for information and education only, not investment advice, a recommendation, or a valuation. Standalone = parent entity; consolidated includes subsidiaries. Historical multiples pair each fiscal year's filed figures with that FY-end market close; the Current column uses the last close with the latest filed annuals. Figures are cross-verified via accounting identities and NSE×BSE agreement — XBRL cross-verified ✓ 95%.